• Amarna Therapeutics Collaborates with Spanish FPS contractpharma
    September 27, 2020
    Will examine the efficacy of its SV40-based SVec gene delivery vector in diabetes mellitus type 1 and multiple sclerosis.
  • Amarna Therapeutics Names New CEO contractpharma
    September 07, 2020
    ​Amarna Therapeutics, a privately held biotechnology company, has appointed Steen Klysner, Ph.D. as its new chief executive officer as per September 1. Founder and CEO Ben van Leent will become a member of Amarna's Supervisory Board.
PharmaSources Customer Service